Genetic variants of methionine metabolism in glioblastoma multiforme patients and controls
MTHFR c.677C>T . | CC . | CT . | TT . | Pearson: χ2; P . | Regression: χ2; P . | |||||
---|---|---|---|---|---|---|---|---|---|---|
Patients (n = 328) | 0.42 | 0.46 | 0.12 | χ2 = 2.30; P = 0.316 | χ2 = 3.55; P = 0.169 | |||||
Controls (n = 400) | 0.46 | 0.46 | 0.09 | |||||||
MTR c.2756A>G | AA | AG | GG | χ2; P | χ2; P | |||||
Patients (n = 328) | 0.72 | 0.26 | 0.02 | χ2 = 17.86; P < 0.001 | χ2 = 14.82; P = 0.001 | |||||
Controls (n = 400) | 0.57 | 0.38 | 0.05 | |||||||
Tc2 c.776C>G | CC | CG | GG | χ2; P | χ2; P | |||||
Patients (n = 328) | 0.28 | 0.46 | 0.26 | χ2 = 0.18; P = 0.912 | χ2 = 0.735; P = 0.693 | |||||
Controls (n = 400) | 0.28 | 0.45 | 0.28 |
MTHFR c.677C>T . | CC . | CT . | TT . | Pearson: χ2; P . | Regression: χ2; P . | |||||
---|---|---|---|---|---|---|---|---|---|---|
Patients (n = 328) | 0.42 | 0.46 | 0.12 | χ2 = 2.30; P = 0.316 | χ2 = 3.55; P = 0.169 | |||||
Controls (n = 400) | 0.46 | 0.46 | 0.09 | |||||||
MTR c.2756A>G | AA | AG | GG | χ2; P | χ2; P | |||||
Patients (n = 328) | 0.72 | 0.26 | 0.02 | χ2 = 17.86; P < 0.001 | χ2 = 14.82; P = 0.001 | |||||
Controls (n = 400) | 0.57 | 0.38 | 0.05 | |||||||
Tc2 c.776C>G | CC | CG | GG | χ2; P | χ2; P | |||||
Patients (n = 328) | 0.28 | 0.46 | 0.26 | χ2 = 0.18; P = 0.912 | χ2 = 0.735; P = 0.693 | |||||
Controls (n = 400) | 0.28 | 0.45 | 0.28 |
NOTE: The rate of carriers of the different allelotypes is given as relative amount. The χ2 test values for Pearson's χ2 test for all three allelotypes (= 2 degrees of freedom) as well as for multiple nominal regression analysis (with simultaneous analysis of all three polymorphisms together with age and gender as covariables) for the differences between patients and controls are shown. The allelic frequencies in the control group are similar to those we reported for another (independent) healthy German population (12).